Abstract
The capacity of pirenzepine to reduce gastric acid secretion in the basal state and after various forms of stimulation is well established by now (Jaup 1981). It is still under discussion whether the ulcer-healing and symptom-relieving effect of pirenzepine is solely due to the moderate acid reduction observed or whether other pharmacological properties such as mucosa protection or motility effects may be of importance (for references see Dotevall 1982).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrahamsson H, Jaup BH, Dotevall G (1982) Effects of different doses of pirenzepine on oesophageal peristalsis in man. In: Dotevall G (ed) Advances in gastroenterology with the antimuscarinic compound pirenzepine. Excerpta Medica, Amsterdam, pp 72–80..
Dotevall G (ed) (1982) Advances in gastroenterology with the selective antimuscarinic compound pirenzepine. Excerpta Medica, Amsterdam
Erckenbrecht E, Berges W, Sonnenberg A, Erckenbrecht J, Wienbeck M (1982) The effect of pirenzepine on esophageal motility. Scand J Gastroenterol 17 [Suppl 72]: 185–190.
Fritsch WP, Schacht U, Scholten T, Hengels KJ, Müller J, Strasser K (1980) Effects of cimetidine and pirenzepine on peroperative electrical vagal stimulation on gastric acid secretion. Scand J Gastroenterol 15: [Suppl 66]: 95–102.
Hurwitz A, Robinson RG, Herrin WF (1977) Prolongation of gastric emptying by oral propantheline. Clin Pharmacol Ther 22: 206–210.
Jaup BH (1981) The mode of action of pirenzepine in man — with special reference to its anticholinergic muscarinic properties. Scand J Gastroenterol 17 [Suppl 68].
Jaup BH, Stockbruegger RW, Dotevall G (1980) Comparison of the action of pirenzepine and 1-hyoscyamine on gastric acid secretion and other muscarinic effects. Scand J Gastroenterol 15 [Suppl 66]: 89–94.
Jaup BH, Abrahamsson H, Virtanen R, Iisalo E (1982) The effect of pirenzepine compared to atropine and 1-hyoscyamine on esophageal peristaltic activity in man. Scand J Gastroenterol 17: 233–239.
Jaup BH, Abrahamsson H, Stockbruegger RW, Rosengren K, Dotevall G (1985) The effect of selective and non-selective antimuscarinics on rectosigmoid motility and gastrointestinal transit. Scand J Gastroenterol 20.
Stacher G, Havlik E, Bergmann H, Schmierer G, Winklehner S (1982) Effects of oral pirenzepine on gastric emptying and antral motor activity in healthy man. Scand J Gastroenterology 17 [Suppl 72]: 153–157.
Stockbruegger RW, Jaup BH, Hammer R, Dotevall G (1979) Inhibition of gastric acid secretion by pirenzepine (LS 519). Scand J Gastroenterol 14: 615–620.
Walan A (1971) Studies on peptic ulcer disease. Acta Med Scand 189 [Suppl 516].
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Stockbrügger, R.W., Jaup, B.H., Abrahamsson, W., Dotevall, G. (1985). Pirenzepine and Gastrointestinal Motility: Differential Effect of Pirenzepine in the Gut. In: Lux, G., Daniel, E.E. (eds) Muscarinic Receptor Subtypes in the GI Tract. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70668-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-70668-4_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70670-7
Online ISBN: 978-3-642-70668-4
eBook Packages: Springer Book Archive